Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications
about
NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward.The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor.Neurotrophin-mimicking peptides at the biointerface with gold respond to copper ion stimuli.NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis.Nerve growth factor inhibitor with novel-binding domain demonstrates nanomolar efficacy in both cell-based and cell-free assay systems.NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells.Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception.[EXPRESS] A third HSAN5 mutation disrupts the Nerve Growth Factor furin cleavage site
P2860
Q37147172-9CCA401A-B822-4B7F-A986-D463DBDD1DC3Q37736982-2145AAE4-ABD5-4842-8C09-8FF5D22A921DQ38736357-8E33AEE8-C1CD-4184-89F7-E8776CE8D0DCQ42041489-1AC015E5-D79C-42A6-B033-015C824DC813Q42285705-5DE13187-8DC2-4CAF-A745-083B76B24E11Q42912907-A7C43899-B4C3-481D-AE11-F70A1E8C88FCQ52684421-3A3D76E3-5F9A-4F5F-B64A-120F5205CE3DQ57295301-89B4959A-308B-450B-89C7-17D00D59B6C1
P2860
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Functional Characterization of ...... e for Therapeutic Applications
@ast
Functional Characterization of ...... e for Therapeutic Applications
@en
Functional Characterization of ...... e for Therapeutic Applications
@nl
type
label
Functional Characterization of ...... e for Therapeutic Applications
@ast
Functional Characterization of ...... e for Therapeutic Applications
@en
Functional Characterization of ...... e for Therapeutic Applications
@nl
prefLabel
Functional Characterization of ...... e for Therapeutic Applications
@ast
Functional Characterization of ...... e for Therapeutic Applications
@en
Functional Characterization of ...... e for Therapeutic Applications
@nl
P2093
P2860
P3181
P1433
P1476
Functional Characterization of ...... e for Therapeutic Applications
@en
P2093
Bruno Bruni Ercole
Elisabetta Coppi
Francesca Malerba
Francesca Paoletti
Riccardo Patacchini
Romina Nassini
Serena Materazzi
Simona Capsoni
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0136425
P407
P577
2015-01-01T00:00:00Z